Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mary Langowski
AddedMar 31, 2024
UpdatedMay 31, 2026
Mary Langowski

Mary Langowski

Board Member, Rising Tide

CrunchbaseLinkedIn

Mary Langowski's Career

Rising Tide
Rising Tide

San Francisco, CA, US

Board Member· Board
Solera Health
Solera Health

Phoenix, AZ, US

Board Member· Board
Advantia Health
Advantia Health

Arlington, VA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mary Langowski's Career

Rising Tide
Rising Tide
Investment FirmInvestment Firm112007San Francisco, CA, US
Board Member· Board

Leadership at Rising Tide

Ossama HassaneinOssama HassaneinBoard Member

Similar to Rising Tide

SpringTide Capital ManagementSpringTide Capital ManagementCambridge, MA, USest. 2018SpringTide Capital ManagementCambridge, MA, US · est. 2018

Venture capital firm investing in tomorrow's leading health tech companies.

Investment Firm41
Rise CapitalRise CapitalSan Francisco, CA, USest. 2013Rise CapitalSan Francisco, CA, US · est. 2013

Global investment firm specializing in financing expansion-stage Internet businesses in Emerging Markets.

Investment Firm14
Spring Tide CapitalSpring Tide CapitalNew York City, NY, USest. 2018Spring Tide CapitalNew York City, NY, US · est. 2018

Spring Tide Capital: A NY-based venture capital firm, investing in private companies since 2018.

Investment Firm6
Uprising VenturesUprising VenturesSan Francisco, CA, USest. 2012Uprising VenturesSan Francisco, CA, US · est. 2012

Uprising: A San Francisco-based seed and early-stage investment fund catalyzing impactful entrepreneurial ventures since 2012.

Investment Firm6
Solera Health
Solera Health
Series C$72.3M1462015Phoenix, AZ, US
Board Member· Board

Leadership at Solera Health

Jody HoltzmanJody HoltzmanBoard Member
Lisa K. FitzpatrickLisa K. FitzpatrickBoard Member
Brenda SchmidtBrenda SchmidtBoard Member
Tami GrahamTami GrahamBoard Member
Matt DownsMatt DownsBoard Member
Matt WandoloskiMatt WandoloskiBoard Member

Similar to Solera Health

SolvSolvSan Francisco, CA, USHealthcare Softwareest. 2016SolvSan Francisco, CA, US · est. 2016

Solv: A software solution provider offering simplified, high-quality, last-minute healthcare.

Late Stage Private · $95M154
Prevounce HealthPrevounce HealthIndianapolis, IN, USHealthcare Softwareest. 2018Prevounce HealthIndianapolis, IN, US · est. 2018

Prevounce: Cloud-based wellness solutions for efficient healthcare management and preventive services.

Series A · $7M35
Advantia Health
Advantia Health
Series D$149.5M7502014Arlington, VA, US
Board Member· Board

Recent news

HerMD opening new women’s health clinics following $18M extensionTechCrunch · 2023

Leadership at Advantia Health

Sean GlassSean GlassFounder
James H. \"Jim\" WebberJames H. \"Jim\" WebberBoard Member
Karen TeitelbaumKaren TeitelbaumBoard Member
Angela WayneAngela WayneCEO
Leslie HenshawLeslie HenshawBoard Member
Ameya AggeAmeya AggeBoard Member

Mary Langowski's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Mary Langowski

Swati AbbottSwati AbbottBoard Member · Prognos HealthLori BushLori BushBoard Member · Ruby RibbonAnthony MarlonAnthony MarlonBoard Member · Stemedica Cell Technologies